CXCL12 and breast cancer: Similarly, low molecular weight heparin (LMWH)-taurocholate conjugated with tetrameric deoxycholic acid, namely LHTD4, inhibits TGF-β1 and CXCL12 mediated migration and invasion of breast cancer cells [129].